John Jannarone – IPO Edge

Cortexyme, Inc. Announces Closing of Initial Public Offering and the Exercise of the Underwriters’ Option to Purchase Additional Shares

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Cortexyme, Inc. (Nasdaq: CRTX), a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat a key underlying cause of Alzheimer’s and other degenerative diseases, today announced the closing of its initial public offering...

Life360 Completes IPO on ASX

SYDNEY–(BUSINESS WIRE)–Life360, Inc. (ASX: 360) is pleased to announce the successful completion of its initial public offering (IPO) of securities and that it has been admitted to the official list of the Australian Securities Exchange (ASX). IPO Summary The IPO...

Input your search keywords and press Enter.